REX News

Research trial for Multiple Sclerosis and REX

By |September 12th, 2017|Rex News|

Research team AIN-Rehab in collaboration with The University of Newcastle, Australia  now has ethics approval to expand the HELLEN research trial using REX to include people living with Multiple Sclerosis. AIN-Rehab continue to work towards the goal of expanding research into the merits of REX for all neurological conditions.  

REX initiates RAPPER III: Clinical Trial in Multiple Sclerosis

By |January 23rd, 2017|Rex News|

Ethics Committee Approval from NHS’s National Institute for Health Research (NIHR) Partnership with East Kent Hospitals University NHS Foundation Trust, and Kent University Rex Bionics Plc (AIM: RXB), is pleased to announce that the ethics committee of the UK NHS’s National Institute for Health Research has approved the start of a clinical trial to evaluate [...]

REX Stroke and Brain Injury Clinical Trial in Australia

By |October 24th, 2016|Rex News|

Rex Bionics Plc (AIM: RXB), the pioneer of the REX Robot technology that enhances the mobility of wheelchair users, is pleased to announce the start of a new clinical trial treating patients who have had a stroke or brain injury, with Robot-Assisted Physiotherapy with REX. The trial is being conducted by the Australian Institute of [...]